22 Nw, LP Trinity Biotech PLC Transaction History

22 Nw, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.57 - $3.02 $1.5 Million - $2.88 Million	-953,728 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$4.46 - $5.2 $51,294 - $59,805	11,501 Added 1.22%	953,728 $4.77 Million
Q1 2018 May 15, 2018	BUY	$5.08 - $6.06 $348,655 - $415,915	68,633 Added 7.86%	942,227 $4.85 Million
Q2 2017 Aug 14, 2017	BUY	N/A	873,594	873,594 $5.24 Million

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $29M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of 22 Nw, LP, based on Form 13F filings with the SEC.

Stay updated on 22 Nw, LP with notifications on news.